List of Tables
    Table 1. Zika Virus Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Zika Virus Vaccines Market Trends
    Table 3. Zika Virus Vaccines Market Drivers
    Table 4. Zika Virus Vaccines Market Challenges
    Table 5. Zika Virus Vaccines Market Restraints
    Table 6. Global Zika Virus Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Zika Virus Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Zika Virus Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Zika Virus Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Zika Virus Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Zika Virus Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Zika Virus Vaccines Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Zika Virus Vaccines Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Zika Virus Vaccines Sales Share by Manufacturer, 2017-2022
    Table 15. Global Zika Virus Vaccines Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Zika Virus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Zika Virus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Vaccines as of 2021)
    Table 18. Top Players of Zika Virus Vaccines in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Zika Virus Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into Zika Virus Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Zika Virus Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Zika Virus Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Zika Virus Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Zika Virus Vaccines Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Zika Virus Vaccines Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Zika Virus Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Zika Virus Vaccines Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Zika Virus Vaccines Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Zika Virus Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Zika Virus Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Zika Virus Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Zika Virus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Zika Virus Vaccines Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Zika Virus Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Zika Virus Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Zika Virus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Zika Virus Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Zika Virus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Zika Virus Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Zika Virus Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. NHI Corporation Information
    Table 43. NHI Description and Business Overview
    Table 44. NHI Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. NHI Zika Virus Vaccines Product
    Table 46. NHI Recent Development
    Table 47. Sanofi Corporation Information
    Table 48. Sanofi Description and Business Overview
    Table 49. Sanofi Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Sanofi Product
    Table 51. Sanofi Recent Development
    Table 52. GSK Corporation Information
    Table 53. GSK Description and Business Overview
    Table 54. GSK Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. GSK Product
    Table 56. GSK Recent Development
    Table 57. Bharat. Corporation Information
    Table 58. Bharat. Description and Business Overview
    Table 59. Bharat. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Bharat. Product
    Table 61. Bharat. Recent Development
    Table 62. Takeda Corporation Information
    Table 63. Takeda Description and Business Overview
    Table 64. Takeda Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Takeda Product
    Table 66. Takeda Recent Development
    Table 67. Inovio Pharmaceuticals Corporation Information
    Table 68. Inovio Pharmaceuticals Description and Business Overview
    Table 69. Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Inovio Pharmaceuticals Product
    Table 71. Inovio Pharmaceuticals Recent Development
    Table 72. GeneOne Life Science Inc Corporation Information
    Table 73. GeneOne Life Science Inc Description and Business Overview
    Table 74. GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. GeneOne Life Science Inc Product
    Table 76. GeneOne Life Science Inc Recent Development
    Table 77. PaxVax Corporation Information
    Table 78. PaxVax Description and Business Overview
    Table 79. PaxVax Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. PaxVax Product
    Table 81. PaxVax Recent Development
    Table 82. Gilead Sciences Inc. Corporation Information
    Table 83. Gilead Sciences Inc. Description and Business Overview
    Table 84. Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. Gilead Sciences Inc. Product
    Table 86. Gilead Sciences Inc. Recent Development
    Table 87. Intrexon Corp. Corporation Information
    Table 88. Intrexon Corp. Description and Business Overview
    Table 89. Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 90. Intrexon Corp. Product
    Table 91. Intrexon Corp. Recent Development
    Table 92. NewLink Genetics Corp Corporation Information
    Table 93. NewLink Genetics Corp Description and Business Overview
    Table 94. NewLink Genetics Corp Zika Virus Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 95. NewLink Genetics Corp Product
    Table 96. NewLink Genetics Corp Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Zika Virus Vaccines Customers List
    Table 100. Zika Virus Vaccines Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Zika Virus Vaccines Product Picture
    Figure 2. Global Zika Virus Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Zika Virus Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. Global Zika Virus Vaccines Sales 2017-2028 (MT)
    Figure 5. United States Zika Virus Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Zika Virus Vaccines Market Size 2017-2028 (US$ Million)
    Figure 7. United States Zika Virus Vaccines Sales 2017-2028 (MT)
    Figure 8. United States Zika Virus Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Zika Virus Vaccines Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Zika Virus Vaccines Report Years Considered
    Figure 11. Product Picture of DNA Vaccine
    Figure 12. Product Picture of Inactivated Vaccine
    Figure 13. Product Picture of Purified Inactivated Vaccine
    Figure 14. Product Picture of Table of Contents
    Figure 15. Global Zika Virus Vaccines Market Share by Type in 2022 & 2028
    Figure 16. Global Zika Virus Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Zika Virus Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Zika Virus Vaccines Sales by Type (2017-2028) & (MT)
    Figure 19. Global Zika Virus Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Zika Virus Vaccines Price by Type (2017-2028) & (USD/Kg)
    Figure 21. United States Zika Virus Vaccines Market Share by Type in 2022 & 2028
    Figure 22. United States Zika Virus Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Zika Virus Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Zika Virus Vaccines Sales by Type (2017-2028) & (MT)
    Figure 25. United States Zika Virus Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Zika Virus Vaccines Price by Type (2017-2028) & (USD/Kg)
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Academic and Research
    Figure 30. Product Picture of Others
    Figure 31. Global Zika Virus Vaccines Market Share by Application in 2022 & 2028
    Figure 32. Global Zika Virus Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Zika Virus Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Zika Virus Vaccines Sales by Application (2017-2028) & (MT)
    Figure 35. Global Zika Virus Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Zika Virus Vaccines Price by Application (2017-2028) & (USD/Kg)
    Figure 37. United States Zika Virus Vaccines Market Share by Application in 2022 & 2028
    Figure 38. United States Zika Virus Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Zika Virus Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Zika Virus Vaccines Sales by Application (2017-2028) & (MT)
    Figure 41. United States Zika Virus Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Zika Virus Vaccines Price by Application (2017-2028) & (USD/Kg)
    Figure 43. North America Zika Virus Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 44. North America Zika Virus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Zika Virus Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 48. Europe Zika Virus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Zika Virus Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 55. Asia-Pacific Zika Virus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Zika Virus Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 67. Latin America Zika Virus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Zika Virus Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 72. Middle East & Africa Zika Virus Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Zika Virus Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Zika Virus Vaccines Value Chain
    Figure 77. Zika Virus Vaccines Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed